C L Kramer1, D R Wetzel2, E F M Wijdicks3. 1. Division of Critical Care Neurology, Mayo Clinic Rochester, Rochester, MN, USA. ckramer82@gmail.com. 2. Department of Anesthesiology, Division of Critical Care, Mayo Clinic Rochester, Rochester, MN, USA. 3. Division of Critical Care Neurology, Mayo Clinic Rochester, Rochester, MN, USA.
Abstract
BACKGROUND: "Bath salts" or synthetic cathinone toxicity remains a potentially deadly clinical condition. We report a delayed leukoencephalopathy with persistent minimally conscious state. METHODS: Case report. RESULTS: A 36-year-old man presents with delayed encephalopathy, dysautonomia, fulminant hepatic failure, and renal failure from severe rhabdomyolysis after consuming bath salts. MRI showed diffusion restriction in the splenium of the corpus callosum and subcortical white matter. CONCLUSIONS: The combination of acute leukoencephalopathy, rhabdomyolysis and fulminant hepatic failure may point to bath salt inhalation and should be known to neurointensivists.
BACKGROUND: "Bath salts" or synthetic cathinonetoxicity remains a potentially deadly clinical condition. We report a delayed leukoencephalopathy with persistent minimally conscious state. METHODS: Case report. RESULTS: A 36-year-old man presents with delayed encephalopathy, dysautonomia, fulminant hepatic failure, and renal failure from severe rhabdomyolysis after consuming bath salts. MRI showed diffusion restriction in the splenium of the corpus callosum and subcortical white matter. CONCLUSIONS: The combination of acute leukoencephalopathy, rhabdomyolysis and fulminant hepatic failure may point to bath salt inhalation and should be known to neurointensivists.
Entities:
Keywords:
3,4-Methylenedioxypyrovalerone (MDPV); Acute liver failure; Bath salts; Bath salts toxicity; Cathinone toxicity; Dysautonomia; Fulminant hepatic failure; Leukoencephalopathy; Minimally conscious state; Neuroimaging; Rhabdomyolysis; Splenium of corpus callosum; Subcortical white matter
Authors: Gregory C Hadlock; Katy M Webb; Lisa M McFadden; Pei Wen Chu; Jonathan D Ellis; Scott C Allen; David M Andrenyak; Paula L Vieira-Brock; Christopher L German; Kevin M Conrad; Amanda J Hoonakker; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein Journal: J Pharmacol Exp Ther Date: 2011-08-02 Impact factor: 4.030
Authors: Edward A Ross; Gary M Reisfield; Mary C Watson; Chris W Chronister; Bruce A Goldberger Journal: Am J Med Date: 2012-06-09 Impact factor: 4.965
Authors: Dawn E Muskiewicz; Federico Resendiz-Gutierrez; Omar Issa; F Scott Hall Journal: Pharmacol Biochem Behav Date: 2020-02-12 Impact factor: 3.533